KRAS and lung adenocarcinoma: One recent report described an adenocarcinoma of the lung with HRAS Q61L mutation suffering from rapid progression and deterioration suggesting that HRAS mutations in NSCLC tumors might be aggressive and associated with poor overall prognosis, similar to KRAS mutant NSCL [6].